Compugen (CGEN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 75%. A quarter ago, it was expected that this drug developer would post a loss of $0.10 per share when it actually produced a loss of $0.08, delivering a surprise of 20%. Over the last four quarters, the company has surpassed co ...